PTC Therapeutics Stock Price (NASDAQ:PTCT)

Add to My Stocks
$47.19 $1.27 (2.77%) PTCT stock closing price Sep 18, 2018 (Closing)
Prev Close* : $45.92
Market Cap:
$2.31B
Day Low: $45.42
52 Week Low: $14.56
Open: $45.81
Volume: -
Day High: $47.52
52 Week High: $52.95
Dividend:
0.00

Latest Stock Market News

Latest Articles

PTC Therapeutics News - From Partners

PTCT Stockcharts

View PTCT PE ratio, PS ratio stocks charts and compare with peers.
PTCT Chart
Note: Compare PTC Therapeutics stock price history with the index and industry peers.

PTC Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
8.9
PB ratio (
price to book ratio
)
12.24

PTC Therapeutics Returns

ROE
(return on equity)
-34%

PTC Therapeutics Financial Ratios

Asset Turnover
0.62
Receivables Turnover
5.62
Debt to Equity
0.56
Dividend Yield
0%

PTCT Industry Peers

Company Price Change (%)
Xencor (XNCR)45.430.08 (0.18%)
Indivior (INVVY)17.950.64 (3.7%)
Avexis (AVXS)217.830 (0%)
Vertex Pharma (VRTX)177.121.32 (0.75%)
Fibrogen (FGEN)57.350.55 (0.97%)
Atyr Pharma (LIFE)0.760.01 (1.33%)
Ionis Pharma (IONS)49.361.17 (2.43%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

PTC Therapeutics, Inc. Stock News - Partner Headlines

PTC Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues194.39M82.7M36.76M25.24M34.69M
Net Income-79M-142.11M-170.44M-93.75M-51.57M
Total Operating Expense254.1M214.76M203.89M124.65M80.08M
View PTC Therapeutics income statement
balance sheet20172016201520142013
Total Assets391.65M269.34M368.04M333.21M151.9M
Total Liabilities235.21M149.76M142.04M34.75M15.36M
Shareholders Equity156.43M119.58M226M298.46M136.54M
View PTC Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities13.22M-8.96M4.69M13.19M-12.31M
Net Cash from (used by) Operating Activities-10.06M-103.56M-124.33M-57.27M-46.92M
Increase (Decrease) in Prop Plant And Equipment-3.1M-1.77M-2.72M-4.66M-0.84M
View PTC Therapeutics cash flow statement

PTC Therapeutics Stock Message Board

PTC Therapeutics stock gained 2.77%, and the last close price as of Sep 18, 2018 is $47.19 for PTCT stock. The total market value as denoted by $2.31B for PTC Therapeutics, is the market value of the company's outstanding shares. PTC Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy PTCT stock than sell it, then PTC Therapeutics stock price goes up. Conversely, if more investors wanted to sell PTCT stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in PTC Therapeutics stock quote data shows the number of shares traded. For Ex: 614,683 PTC Therapeutics shares were traded as of last trading day, as seen from PTC Therapeutics stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. PTC Therapeutics stock dividend was 0.00 during the last quarter. PTC Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.